Search the GHTC website
Dr. David Kaslow is Vice President of Product Development at PATH, a global nonprofit dedicated to ending health inequity.

Blog posts written by David

Total of 1 blog post

August 13, 2014

A new era for malaria treatment

In this post, PATH Vice President of Product Development, David Kaslow, writes about the first-ever shipment of semisynthetic artemisinin (ssART)—a new type of malaria treatment that marks a significant milestone in the fight against malaria.